Azilect
Takeda trials Teva Parkinson’s drug in Japan
January 9, 2015Sales and Marketing Azilect, CHMP, Copaxone, Parkinson's, Takeda, rasagiline
Takeda has begun late stage trials for Teva’s Parkinson’s disease drug Azilect in Japan, with the hopes of bringing the …
Teva under investigation for marketing practices
February 12, 2014Sales and Marketing Azilect, Copaxone, Teva, fines, generics
Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …
Lundbeck issues Lexapro patent warning
November 3, 2010Sales and Marketing Azilect, Cipralex, Forest Laboratories, Lexapro, Lundbeck, Xenazine
Neurological disorder specialist Lundbeck has posted a modest growth in revenue for the third quarter, but warned the looming patent …
Lundbeck delivers strong results and builds on pipeline
May 7, 20102010 financials, Azilect, Lundbeck
Denmark-based Lundbeck has seen a large jump in revenue for the first quarter thanks to steady growth from its lead …
Lundbeck and Teva launch Azilect in France
January 20, 2010Sales and Marketing Azilect, France, Lundbeck, Teva
Lundbeck and Teva France have launched Azilect in France following the successful conclusion of pricing and reimbursement discussions with the …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
